Studies will advance research on the role of bacteria in glioblastoma multiforme (GBM), the most common brain tumor.

The CRI-ICRF Clinic and Laboratory Integration Program (CLIP) Grant to Fund Promising Immunotherapy Research in Israel Awarded to Yifat Merbl, PhD, of the Weizmann Institute of Science.